Limba
|
Brivanib is an ATP-competitive inhibitor against VEGFR2with IC50of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Phase 3.
Price | 1.119,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Brivanib is an ATP-competitive inhibitor against VEGFR2with IC50of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Phase 3. |